Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European UnionGlobeNewsWire • 09/16/22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European UnionGlobeNewsWire • 09/12/22
BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMOGlobeNewsWire • 09/09/22
BioNTech CEO Ugur Sahin Visited Israel to Discuss Cooperation on Pandemic Preparedness and the Development of Innovative MedicinesGlobeNewsWire • 09/07/22
Moderna, BioNTech Jump After CDC Green-Lights Updated Covid BoostersInvestors Business Daily • 09/02/22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European UnionBusiness Wire • 09/01/22
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and OlderBusiness Wire • 08/31/22
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and GermanyMarket Watch • 08/26/22
Report finds Americans losing up to $1 billion in wages from long COVID, and Moderna sues Pfizer and BioNTech over mRNA patentsMarket Watch • 08/26/22
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent VaccineBusiness Wire • 08/26/22
Moderna Claims Pfizer, BioNTech Stole Its Patented Tech In Covid ShotInvestors Business Daily • 08/26/22
Moderna sues Pfizer and BioNTech for patent infringement relating to the mRNA platform used to develop COVID vaccinesMarket Watch • 08/26/22
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorizationMarket Watch • 08/24/22